Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions.

Seifert PS, Hugo F, Tranum-Jensen J, Zâhringer U, Muhly M, Bhakdi S.

J Exp Med. 1990 Aug 1;172(2):547-57.

2.
3.
4.

Human hyperimmune globulin protects against the cytotoxic action of staphylococcal alpha-toxin in vitro and in vivo.

Bhakdi S, Mannhardt U, Muhly M, Hugo F, Ronneberger H, Hungerer KD.

Infect Immun. 1989 Oct;57(10):3214-20.

5.
6.

Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes.

Bhakdi S, Greulich S, Muhly M, Eberspächer B, Becker H, Thiele A, Hugo F.

J Exp Med. 1989 Mar 1;169(3):737-54.

7.

Staphylococcal alpha toxin promotes blood coagulation via attack on human platelets.

Bhakdi S, Muhly M, Mannhardt U, Hugo F, Klapettek K, Mueller-Eckhardt C, Roka L.

J Exp Med. 1988 Aug 1;168(2):527-42.

8.

The cytolytic C5b-9 complement complex: feedback inhibition of complement activation.

Bhakdi S, Maillet F, Muhly M, Kazatchkine MD.

Proc Natl Acad Sci U S A. 1988 Mar;85(6):1912-6.

9.

A reason for the cytolytic inefficiency of murine serum.

Sassi F, Hugo F, Muhly M, Khaled A, Bhakdi S.

Immunology. 1987 Sep;62(1):145-7.

10.

A natural auto-inhibitory factor of the terminal complement pathway in serum of Ctenodactylus gondi.

Sassi F, Hugo F, Muhly M, Khaled A, Ben Rachid MS, Bhakdi S.

Mol Immunol. 1987 May;24(5):543-8.

PMID:
3309625
11.

Formation of transmural complement pores in serum-sensitive Escherichia coli.

Bhakdi S, Kuller G, Muhly M, Fromm S, Seibert G, Parrisius J.

Infect Immun. 1987 Jan;55(1):206-10.

12.
13.
14.
15.

A simple immunoradiometric assay for the terminal SC5b-9 complex of human complement.

Bhakdi S, Muhly M.

J Immunol Methods. 1983 Feb 25;57(1-3):283-9.

PMID:
6827108
16.

Preparation and isolation of specific antibodies to complement components.

Bhakdi S, Muhly M, Roth M.

Methods Enzymol. 1983;93:409-20. No abstract available.

PMID:
6865785

Supplemental Content

Support Center